Genotypic investigation of Clostridium difficile in

[1]  N. Verlander,et al.  Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study , 2008, PloS one.

[2]  A. Goorhuis,et al.  Clostridium difficile PCR Ribotype 078: an Emerging Strain in Humans and in Pigs? , 2008, Journal of Clinical Microbiology.

[3]  L. Valiquette,et al.  Outcomes of Clostridium difficile-Associated Disease Treated With Metronidazole or Vancomycin Before and After the Emergence of NAP1/027 , 2007, The American Journal of Gastroenterology.

[4]  M. Delmée,et al.  Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  C. Visser,et al.  Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  E. Kuijper,et al.  Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Wilcox,et al.  Clostridium difficile: changing epidemiology and new treatment options , 2007, Current opinion in infectious diseases.

[8]  B. Dupuy,et al.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC , 2007, Molecular microbiology.

[9]  M. Dionne,et al.  A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Jane W. Marsh,et al.  tcdC Genotypes Associated with Severe TcdC Truncation in an Epidemic Clone and Other Strains of Clostridium difficile , 2006, Journal of Clinical Microbiology.

[11]  T. Louie,et al.  Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada , 2006, Journal of Clinical Microbiology.

[12]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[13]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[14]  J. Weese,et al.  Use of a Selective Enrichment Broth To Recover Clostridium difficile from Stool Swabs Stored under Different Conditions , 2005, Journal of Clinical Microbiology.

[15]  Jon Brazier,et al.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.

[16]  J. Brazier,et al.  Subtyping of Clostridium difficile PCR ribotype 001 by REP-PCR and PFGE. , 2005, Journal of medical microbiology.

[17]  C. Branger,et al.  Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. , 2005, Journal of medical microbiology.

[18]  J. Lemeland,et al.  Multiplex PCR Targeting tpi (Triose Phosphate Isomerase), tcdA (Toxin A), and tcdB (Toxin B) Genes for Toxigenic Culture of Clostridium difficile , 2004, Journal of Clinical Microbiology.

[19]  Louis Valiquette,et al.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.

[20]  D. Decré,et al.  Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile , 2004, Journal of Clinical Microbiology.

[21]  M. Rupnik,et al.  Binary toxin producing Clostridium difficile strains. , 2003, Anaerobe.

[22]  P. Mastrantonio,et al.  Molecular Analysis of the Pathogenicity Locus and Polymorphism in the Putative Negative Regulator of Toxin Production (TcdC) among Clostridium difficile Clinical Isolates , 2002, Journal of Clinical Microbiology.

[23]  C. Klaassen,et al.  Molecular Fingerprinting of Clostridium difficile Isolates: Pulsed-Field Gel Electrophoresis versus Amplified Fragment Length Polymorphism , 2002, Journal of Clinical Microbiology.

[24]  M. Alfa,et al.  Characterization of a Toxin A-Negative, Toxin B-Positive Strain of Clostridium difficile Responsible for a Nosocomial Outbreak of Clostridium difficile-Associated Diarrhea , 2000, Journal of Clinical Microbiology.

[25]  M. Delmée,et al.  Comparison of PCR-Ribotyping, Arbitrarily Primed PCR, and Pulsed-Field Gel Electrophoresis for Typing Clostridium difficile , 2000, Journal of Clinical Microbiology.

[26]  M. Rupnik,et al.  Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. , 2000, FEMS microbiology letters.

[27]  P. Bidet,et al.  Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. , 1999, FEMS microbiology letters.

[28]  M. Delmée,et al.  A Novel Toxinotyping Scheme and Correlation of Toxinotypes with Serogroups of Clostridium difficileIsolates , 1998, Journal of Clinical Microbiology.

[29]  Kunitomo Watanabe,et al.  Identification of Toxin A-Negative, Toxin B-Positive Clostridium difficile by PCR , 1998, Journal of Clinical Microbiology.